Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 01)
Quinapril
Product Images NDC 50090-4649
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quinapril (NDC 50090-4649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 02)
This appears to be a table of the incidence and discontinuance of symptoms in a placebo-controlled trial conducted by Aiversa Events. It lists various symptoms such as headache, dizziness, fatigue, coughing, nausea and vomiting, and abdominal pain, along with their incidence and discontinuance rates. However, as the text seems to be full of errors and misspelled words, the accuracy and usefulness of this information is questionable.*
Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 03)
Label Image (Lbl500904649)
This is a product with the number 5711-0 and it contains 30 tablets. The remaining text is not readable.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
